Policy & Regulation
18 November 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE: BMY) on Wednesday reported preliminary results from two Phase 3 studies evaluating investigational drug KarXT (xanomeline and t...
18 November 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) announced on Wednesday that it has entered into an exclusive licensing agreement with biotechnology company Starna Therapeutics to...
18 November 2026 - DDL, a third-party testing laboratory specialising in medical device and pharmaceutical packaging, combination products, and materials testing, announced on Tuesday that it has laun...
18 November 2026 - Inhibrx Biosciences Inc (Nasdaq:INBX), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, announced on Tuesday updated clinical ...
18 November 2026 - Swedish pharmaceutical company Dicot Pharma AB (Nasdaq First North:DICOT) announced on Wednesday that it has initiated the phase 2b clinical study of LIB-01, its investigational tre...
17 November 2026 - Swedish biopharmaceutical company Sobi (STO: SOBI), which focuses on rare diseases, said on Tuesday that the European Commission has approved Tryngolza (olezarsen) for adults with s...